Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared

Trends in Molecular Medicine

Volumn 8, Issue 1, 2002, Pages 10-16

  Rhodes, Jonathan M ^a   Campbell, Barry J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; COLON CROHN DISEASE; COLON FLORA; COLORECTAL CANCER; DISEASE ASSOCIATION; ENTERITIS; PATHOGENESIS; REVIEW; ULCERATIVE COLITIS;

COLORECTAL NEOPLASMS; DNA DAMAGE; GLYCOSYLATION; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MODELS, BIOLOGICAL;

EID: 0036138686     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02194-3     Document Type: Review

References (69)

1. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
2. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
3. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: Implications for carcinogenesis and prevention
4. Unifying hypothesis for inflammatory bowel disease and related colon cancer: Sticking the pieces together with sugar
5. Ulcerative colitis and colorectal cancer. A population-based study
6. Small intestinal adenocarcinoma complicating regional ileitis
7. The relationship between fistulas in Crohn's disease and associated carcinoma: Report of 4 cases and review of the literature
8. The aetiology and surgery of carcinoma of the anus, rectum and sigmoid colon in Crohn's disease. Negative correlation with human papillomavirus type 16 (HPV 16)
9. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: A population-based cohort study
10. Colonic adenocarcinoma associated with chronic colitis in cotton top marmosets, Saguinus oedipus
11. Family history as a risk factor for colorectal cancer in inflammatory bowel disease
12. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias
13. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice
14. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis
15. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis
16. Top-down morphogenesis of colorectal tumors
17. Inflammatory bowel disease and cancer
18. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
19. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1
20. Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Observer variation and correlations
21. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer
22. Glycosylation and disease
23. Direct demonstration of increased expression of Thomsen-Friedenreich antigen (Galβ1 - 3GalNAc) by mucus in colon cancer and inflammatory bowel disease
24. Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: Relation to dyplasia and DNA aneuploidy
25. Eating peanuts increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor
26. Lectins, colitis and colon cancer
27. Consumption of peanuts, which contain a galactose-binding lectin, associates with increased risk for colorectal cancer whereas high non-starch polysaccharide galactose intake associates with reduced risk
28. Review article: Cyclooxygenase - A target for colon cancer prevention
29. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
30. The contributions of cyclooxygenase-2 to tumor angiogenesis
31. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
32. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
33. Cytokine-mediated PGE2 expression in human colonic fibroblasts
34. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice
35. Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice
36. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis
37. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
38. Intracellular unesterified arachidonic acid signals apoptosis
39. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia
40. Colorectal cancer prevention in ulcerative colitis: A case-control study
41. A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid
42. Cytokine gene transcription by NF-κB family members in patients with inflammatory bowel disease
43. The IκB/NF-κB system: A key determinant of mucosal inflammation and protection
44. NF-κB signalling proteins as therapeutic targets for inflammatory bowel diseases
45. Enterocolitis and colon cancer in interleukin 10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
46. Lessons from genetically engineered animal models. XII. IL-deficient IL-10(-/-) mice and intestinal inflammation
47. Lessons from genetically engineered animal models VII. Apoptosis in intestinal epithelium: Lessons from transgenic and knockout mice
48. A proinflammatory cytokine inhibits p53 tumor suppressor activity
49. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
50. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer
51. NF-κB anti-apoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
52. Cancer metastasis determined by carbohydrate-mediated cell adhesion
53. Influence of sulphate groups in the binding of peanut agglutinin. Histochemical demonstration with light- and electron-microscopy
54. Characterization of a novel mucin sulphotransferase activity synthesizing sulphated O-glycan core 1,3-sulphate-Gal beta 1-3GalNAc alpha-R
55. Alterations of O-glycan biosynthesis in human colon cancer tissues
56. Increasing the intra-Golgi pH of cultured LS174T goblet-differentiatied cells mimics the decreased mucin sulphation and increased Thomsen-Friedenreich antigen (Galβ1-3GalNAcα-) expression seen in colon cancer
57. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr)
58. TNFα decreases the sulphation of mucins and CD44 in human colonic epithelial cells: An effect which may explain the low mucosal sulphation seen in inflammatory bowel disease
59. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44
60. Increase of rat colon carcinoma cells tumorigenicity by α(1-2) fucosyltransferase gene transfection
61. CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features
62. Interleukin 4 and 13 upregulate expression of CD44 in human colonic epithelial cell-lines
63. CD44 regulation and function in ulcerative colitis
64. Influence of cytokines on the expression of fas ligand and CD44 splice variants in colon carcinoma cells
65. Influences of microbiota on intestinal immune system development
66. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease
67. Association between intraepithelial Escherichia coli and colorectal cancer
68. Inflammation and cancer: Back to Virchow?
69. Colon carcinogenesis in inflammatory bowel disease